On September 11, 2018, seminar on pharmaceutical exipients and coating material application " hosted by JRS company and co-organized by Standard Pharma was successfully held in Westin hotel, Guangzhou.
From Guangzhou, Foshan, Zhuhai, Zhongshan, Shenzhen, Huizhou and other cities of nearly 30 pharmaceutical companies, CRO companies and research institutes, a total of more than 110 people attended the seminar. Together with JRS technology and legal people , they deeply discusses the application of microcrystalline cellulose and solutions to problems, and the latest regulations released by the Chinese authorities.
During the one-day meeting, JRS's technical and legal staff Shared the following themes with their counterparts in the heat wave of Quality Consistency Re-evaluation.
Dr. Meifania Kohn, global technology center application manager from JRS headquarters, Germany
- "How to select the correct microcrystalline cellulose specifications and the application of specific microcrystalline cellulose specifications"
- "The application of PROSOL ® based on the co-processing technology of high functional pharmaceutical excipients
- "The formula and process challenges in slow and controlled release drug delivery system based on pellet pressure tablet technology"
Mr. Zhang wei, technical manager of JRS China pharmaceutical department
- 'The application of starch hydrolysis oligosaccharide EMDEX ® "
- The introcation of JRS coating product VIVACOAT ® and the solution of common problems in the coating process"
- The ideal lubricant for challenging formula - stearic fumaric acid sodium PRUV ®"
Ms. Zhu jing, legal affairs manager of JRS China pharmaceutical department
- "JRS regulatory strategy under the new regulatory system for pharmaceutical exipients in China"
Mr. Guan yonghong, general manager of Standard Pharma
- Introduction to Guangzhou Standard Pharma Ltd..
The JRS solution for solid oral drug was of great concern to participants, who had heated discussion with technical personnel both for common microcrystalline cellulose, and co-processing PROSOL ®, At the same time, the review of regulations and the analysis of DMF system in China also provided more detailed information for participants.
Our general manage Mr. Guan's business introduction, also let the participants fully understand the professional services.
This seminar provides pharmaceutical research and development, production enterprises with more unique solutions and broader research and development ideas.After the meeting, we have received a large number of sample requirements.
We will continue to cooperate with our principles and hold more seminars to help pharmaceutical enterprises pass the Quality Consistency Re-evaluation successfully!